Abbott registers observational study on Merlin ECG method for pacemaker lead placement
Abbott listed a new trial comparing a simplified ECG approach on its Merlin programmers against standard 12-lead ECG during left bundle branch area pacing.
Abbott Medical Devices registered one new trial this week.
- "Merlin Expanded ECG in Left Bundle Branch Area Pacing" (NCT07877805) is a prospective, observational study evaluating whether a simplified ECG method on the Merlin™ 3650 or MER3700 programmer matches the standard 12-lead ECG during left bundle branch area pacing in patients getting a pacemaker for bradycardia.1 The study is not yet recruiting, with an estimated start date of 2026-10-05, and plans to enroll approximately 50 subjects across up to 5 U.S. sites.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.